Sintx Technologies (SINT) FCF Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249,967.00 |
| Dec 31, 2025 | 113,069.00 |
| Sep 30, 2025 | 206,922.00 |
| Jun 30, 2025 | -81,367.00 |
| Mar 31, 2025 | 128,340.00 |
| Dec 31, 2024 | 38,552.00 |
| Sep 30, 2024 | 64,345.00 |
| Jun 30, 2024 | 67,879.00 |
| Mar 31, 2024 | 132,840.00 |
| Jun 30, 2023 | -46,131.00 |
| Mar 31, 2023 | -85,117.00 |
| Dec 31, 2022 | -37,176.00 |
| Sep 30, 2022 | -62,414.00 |
| Jun 30, 2022 | -115,599.00 |
| Mar 31, 2022 | -256,258.00 |
| Dec 31, 2021 | -169,063.00 |
| Sep 30, 2021 | -201,754.00 |
| Jun 30, 2021 | -269,086.00 |
| Mar 31, 2021 | -311,017.00 |
| Dec 31, 2020 | -191,043.00 |
| Sep 30, 2020 | -328,193.00 |
| Jun 30, 2020 | -73,022.00 |
| Mar 31, 2020 | -158,321.00 |
| Dec 31, 2019 | -55,706.00 |
| Sep 30, 2019 | -90,495.00 |
| Jun 30, 2019 | -85,471.00 |
| Mar 31, 2019 | -170,745.00 |
| Jun 30, 2018 | -13,224.00 |
| Mar 31, 2018 | -7,457.00 |